DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
CAH logo

Cardinal Health, Inc. Stock Price

NYSE:CAH Community·US$54.6b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 107 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CAH Share Price Performance

US$234.89
84.62 (56.31%)
​
US$270.94
Fair Value
US$234.89
84.62 (56.31%)
13.3% undervalued intrinsic discount
US$270.94
Fair Value
Price US$234.89
AnalystConsensusTarget US$270.94
Wed, 26 Aug 26
Fair ValueUS$270.94
Share Pricen/a

CAH Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$270.94 13.3% undervalued intrinsic discount

CAH: Core Pharmaceutical Trends And Automation Will Shape Upcoming Earnings Performance

0users have liked this narrative
0users have commented on this narrative
49users have followed this narrative
CAH logo
Cardinal Health
13.3% undervalued intrinsic discount

CAH: Core Pharmaceutical Trends And Automation Will Shape Upcoming Earnings Performance

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 26 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
CAH logo

CAH: Higher-Margin Services And Generics Will Support EPS Delivery Into FY27

Fair Value: US$270.94 13.3% undervalued intrinsic discount
49 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Average dividend payer and fair value.

3 Risks
3 Rewards
View Full Analysis

Cardinal Health, Inc. Key Details

US$254.2b

Revenue

US$244.5b

Cost of Revenue

US$9.8b

Gross Profit

US$8.1b

Other Expenses

US$1.7b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
7.37
3.84%
0.67%
-321.3%
View Full Analysis

About CAH

Founded
1979
Employees
61344
CEO
Jason Hollar
WebsiteView website
www.cardinalhealth.com

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Recent CAH News & Updates

User avatar
Narrative Update • Aug 26

CAH: Higher-Margin Services And Generics Will Support EPS Delivery Into FY27

The analyst fair value estimate for Cardinal Health has increased from $264.73 to $270.94 as analysts factor in higher expected margins from integrated services, contributions from Sonexus and nuclear medicine, and updated Street price targets that now generally fall in the mid to high $200s. Analyst Commentary Recent Street research on Cardinal Health points to a cluster of higher price targets and generally constructive views on execution in pharma distribution, integrated services, and earnings visibility into fiscal 2027.

Recent updates

No updates

Cardinal Health, Inc. Competitors

UNH logo

UnitedHealth Group

Symbol: NYSE:UNH
Market cap: US$340.3b
ABT logo

Abbott Laboratories

Symbol: NYSE:ABT
Market cap: US$176.4b
ISRG logo

Intuitive Surgical

Symbol: NasdaqGS:ISRG
Market cap: US$130.4b
CVS logo

CVS Health

Symbol: NYSE:CVS
Market cap: US$121.1b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide